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arteriosus and pulmonary hypertension. The PDA was closed percutaneously using the new
Amplatzer Ductal Occluder device type II.
ª 2010 King Saud University. All rights reserved.1. Clinical information
A 3 week old infant was diagnosed to have Scimitar syndrome
with right lung hypoplasia and dextroposition of the heart
during a work-up for respiratory illness requiring mechanical
ventilation. Echocardiographic evaluation showed right pul-
monary artery hypoplasia, a moderate patent ductus arteriosus
(PDA) and small atrial septal defect secundum type. CT angio-
gram of the chest showed right lung hypoplasia, anomalous. Box 22490, Riyadh 11426,
x: +966 1 252 0142.
(O.R.J. Tamimi).
ity. All rights reserved. Peer-
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lsevierpulmonary venous drainage to the inferior vena cava above
the liver and aorta-pulmonary (AP) collateral to the right lung.
The clinical condition did not improve with respiratory therapy.
Transcatheter A-P collateral coiling was done at the age of four
weeks. At that time the mean pulmonary artery pressure was
30 mmHg. The PDA was left open in the hope of spontaneous
closure. The patient’s condition improved and he was dis-
charged home in a stable condition. A few weeks later he was
readmitted with severe respiratory illness which needed
mechanical ventilation oncemore. The patient failed extubation
twice. The patient was re-evaluated by echocardiography and
the PDAwas still patent with left to right shunting and evidence
of pulmonary hypertension. The tricuspid regurgitation veloc-
ity was 4 m/s. The parents were counselled and agreed to car-
diac catheterisation for PDA closure.
The patient weight was 4 kg and length was 50 cm. Under
general anaesthesia, cardiac catheterisation was performed.
The pulmonary artery (PA) pressure was 68/32 with a mean
of 44 mmHg, the mean left and right pulmonary artery wedge
pressure was 3 mmHg, the aortic pressure was 86/32/50 and
66 O.R.J. Tamimi et al.the systemic to pulmonary shunt (Qp:Qs) was 3:1. After bal-
loon test closure of the PDA the PA pressure dropped to 47/
12 with a mean of 24 mmHg. After conﬁrming that the pul-
monary vasculature was reactive to 100% oxygen and inhaled
nitric oxide (NO) the PDA was closed with a 5 mm/6 mm
Amplatzer Duct Occluder type II Device (ADOII) (AGA
Medical Corporation, Golden Valley, MN) using the standard
technique of Transcatheter closure of PDA described for the
Amplatzer Duct Occluder type I (ADO I) (Thanopoulos
et al., 2001). An aortogram before device release showed no
residual PDA and no aortic or pulmonary artery obstruction
(Fig. 1A–D). He was started on sildenaﬁl and after 24 h the pa-
tient was extubated with minimal oxygen requirement and then
discharged home in a stable condition. On follow up sildenaﬁl
was discontinued and the patient is doing well.
2. Discussion
Scimitar syndrome is a rare congenital disorder that is charac-
terized by dextroposition of the heart, hypoplasia of the rightFigure 1 (A) Pulmonary angiogram: small and tortuous right pulmon
pulmonary collateral to the right lung (coil). (B) Lateral view of th
aortogram after device closure showing the device in position with p
showing the device in position with patent left and right pulmonary apulmonary artery, underdevelopment of the right lung, abnor-
mal connection of the right pulmonary veins to the inferior
vena cava-right atrial junction, and anomalous systemic arte-
rial supply to the right lower lung, often to its basal segments
(Gao et al., 1993; Gudjonsson and Brown, 2006). The infantile
form is sometimes associated with pulmonary hypertension,
cardiac failure, and a worse prognosis (Dupuis et al., 1993).
This case presented with infantile form with PDA and pulmon-
ary hypertension with the PDA contributing signiﬁcantly to his
clinical condition.
Whether a signiﬁcant PDA is closed surgically or percuta-
neously may depend up on the PDA diameter and the patient
size. For PDA device closure using the usual device (i.e.
ADO1) a minimum weight of ﬁve kilogram is recommended
(Thanopoulos et al., 2001).
Since the start of transcatheter PDA closure more than
three decades ago, several devices had been developed for this
purpose (Porstmann et al., 1971).
PDA with pulmonary hypertension is a challenging combi-
nation. There are many case reports of PDA device closure inary artery (RPA) and dilated left pulmonary artery (LPA). Aorta-
e aortogram: large patent ductus arteriosus (PDA). (C) Lateral
atent aortic arch. (D) Pulmonary angiogram after device closure
rteries.
Transcatheter closure of patent ductus arteriosus 67these cases using different types of devices (Yan et al., 2007;
Thanopoulos et al., 2002). Device over sizing (using ADO 1)
to close a PDA associated with pulmonary hypertension to in-
crease the occlusion rate and to prevent the risk of device
embolisation has been described in adult patients (Thanopou-
los et al., 2002).
Recently, transcatheter closure of PDA with Amplatzer
Ductal Occluder type II has been reported (Thanopoulos
et al., 2008).
In our case oversizing and device choices were limited but
the new ADO II device offered a good choice as it has two
relatively small discs giving more device stability and less
risk for embolisation. The use of small device with one disc
(ADO1) in the setting of pulmonary hypertension might ex-
pose the patient to the risk of device embolisation to the
aorta.
Two disc devices have the risk of obstructing or compro-
mising the aorta and/or the pulmonary arteries, especially
the left pulmonary artery (Pass et al., 2004).
In the new ADO II device the aortic disc is smaller
than the pulmonary artery disc. Moreover the pulmonary
arteries are usually dilated in the setting of pulmonary
hypertension, which was the case in our patient, with a
low risk of compromisation of the aortic and pulmonary
blood ﬂow.
This case illustrates that symptomatic patients with
Scimitar syndrome can be managed in the cardiac catheteriza-
tion laboratory thus avoiding the need for surgical interven-
tion early in live.References
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